Clinical trial
Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing…
NCT00273858 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00273858 |
|---|---|
| Title | Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis |
| Official title | Open Label Study To Evaluate The Safety Profile And The Quality Of Life In Patients Receiving Etanercept For The Treatment Of Rheumatoid Arthritis, Ankylosing Spondylitis And Psoriatic Arthritis |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Ankylosing Spondylitis, Arthritis, Psoriatic, Rheumatoid, Spondylitis, Ankylosing |
| Intervention type | Other |
| Interventions | There is no Intervention. The study is observational. |
| Enrollment | 880 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Jan 9, 2006 |
| Last update posted | Sep 12, 2011 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: